Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSINOPRIL vs FOSTAMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSINOPRIL vs FOSTAMATINIB: Safety Overview

Metric FOSINOPRIL FOSTAMATINIB
Total FAERS Reports 461 6,394
Deaths Reported 36 453
Death Rate 7.8% 7.1%
Hospitalizations 219 1,493
Average Patient Age 66.1 yrs 64.7 yrs
% Female Patients 41.5% 60.8%
FDA Approval Date Apr 20, 2005 Apr 17, 2018
Manufacturer Chartwell RX, LLC Rigel Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription